Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03878199
Brief Title: Cytarabine and Daunorubicin in Combination With Ruxolitinib for the Treatment of Secondary Acute Myeloid Leukemia Transformed From Myeloproliferative Neoplasms.

First Submitted : March 11, 2019
First Submitted that Met QC Criteria : March 13, 2019
First Posted : March 18, 2019

Last Update Submitted that Met QC Criteria : March 13, 2019
Last Update Posted : March 18, 2019